• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Virtus LifeSci Biotech Products ETF (NY:BBP)

82.09 -1.58 (-1.88%)
Streaming Delayed Price Updated: 3:24 PM EST, Mar 5, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 6,687
Open 82.76
Bid (Size) 81.81 (200)
Ask (Size) 82.00 (200)
Prev. Close 83.67
Today's Range 81.60 - 83.13
52wk Range 48.65 - 87.17
Shares Outstanding 3,500
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Liquidia Stock Gains Premarket On Q4 Revenue Beat – Investors Are Betting On YUTREPIA Growth ↗
Today 7:39 EST
Product revenue from YUTREPIA reached approximately $148.3 million in 2025, including about $90.1 million generated during the fourth quarter alone. 
Via Stocktwits
Topics Artificial Intelligence
News headline image
IBRX Stock Rises Pre-Market After ANKTIVA Combo Shows Stronger Bladder Cancer Responses In Phase 2 Trial ↗
February 26, 2026
The company said it plans to submit a biologics license application by the fourth quarter of 2026. 
Via Stocktwits

Performance

YTD
+3.0%
+3.0%
1 Month
-0.8%
-0.8%
3 Month
+4.8%
+4.8%
6 Month
+18.4%
+18.4%
1 Year
+36.4%
+36.4%

More News

Read More
News headline image
Merck Germany Buys US Cancer Drugmaker SpringWorks Therapeutics For Around $4 Billion ↗
April 28, 2025
Via Benzinga
News headline image
FDA Set To Approve COVID-19 Vaccines As Soon As This Week: Stocks, ETFs To Watch ↗
August 19, 2024
Via Benzinga
Topics ETFs
News headline image
5 ETFs Riding High On The Biotech Comeback ↗
July 09, 2022
Via Talk Markets
News headline image
Biotech ETFs That Outperformed Last Week ↗
December 20, 2021
Via Talk Markets

Frequently Asked Questions

Is Virtus LifeSci Biotech Products ETF publicly traded?
Yes, Virtus LifeSci Biotech Products ETF is publicly traded.
What exchange does Virtus LifeSci Biotech Products ETF trade on?
Virtus LifeSci Biotech Products ETF trades on the New York Stock Exchange
What is the ticker symbol for Virtus LifeSci Biotech Products ETF?
The ticker symbol for Virtus LifeSci Biotech Products ETF is BBP on the New York Stock Exchange
What is the current price of Virtus LifeSci Biotech Products ETF?
The current price of Virtus LifeSci Biotech Products ETF is 82.09
When was Virtus LifeSci Biotech Products ETF last traded?
The last trade of Virtus LifeSci Biotech Products ETF was at 03/05/26 03:24 PM ET
What is the market capitalization of Virtus LifeSci Biotech Products ETF?
The market capitalization of Virtus LifeSci Biotech Products ETF is 287.33K
How many shares of Virtus LifeSci Biotech Products ETF are outstanding?
Virtus LifeSci Biotech Products ETF has 287K shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap